| Predicate |
Object |
| contentType |
Letter|Research Support, N.I.H., Extramural|Comment |
| endingPage |
642 |
| issn |
1537-6591
1058-4838 |
| issueIdentifier |
4 |
| pageRange |
642-642 |
| publicationName |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
| startingPage |
642 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_274de0cd095daad44a563971b32f4582
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3da5d5672f7fa276ad729c4704fe280d |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_880d13559c1acb28bc1bc43da2c6b612
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d59de0b7b73623e9760365cc980634b9 |
| bibliographicCitation |
Yang Y, Meng Y, Halloran ME, Longini IM. Reply to Aguiar and Stollenwerk. Clin Infect Dis. 2018 Feb 01;66(4):642. PMID: 29088434; PMCID: PMC5848237. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_302a7f678d9c93dcf7ed3e7806825674
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f76248e56333c8788a99d16ad1f9eb0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74143d43ebd432ec36e3f8f3133ec9b3 |
| date |
2017-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.1093/cid/cix883
https://pubmed.ncbi.nlm.nih.gov/PMC5848237
https://pubmed.ncbi.nlm.nih.gov/29088434 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1058-4838
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1135
https://portal.issn.org/resource/ISSN/1537-6591 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Reply to Aguiar and Stollenwerk |
| discusses |
http://id.nlm.nih.gov/mesh/M0022453
http://id.nlm.nih.gov/mesh/M0491092 |